Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
This guide compares risk profiles of index funds and bonds in retirement, helping you choose allocations that align with your comfort and goals.
28,591 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Alphabet’s Q1 2026 results show stronger-than-expected search growth and record cloud momentum, challenging the AI be...
Ukraine’s drone strikes on Russian supply lines intensify funding strains as deficits widen and reserves shrink. This...
As 2026 unfolds, a $1,000 split between XRP and SOL tests volatility, regulatory clarity, and upgrade momentum. This ...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
LBank Pay now supports direct multi-asset payments, including BTC and ETH, eliminating pre-conversion steps. The upgr...
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...
RedotPay, a hong kong-based stablecoin payments company, is weighing a U.S. IPO that could raise more than $1 billion...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
Tether International has finalized a deal to buy SoftBank’s minority stake in Twenty One Capital (XXI), propelling th...
Anthropic's best ever model claude projects XRP climbing to 4.50 by late 2026, signaling a potential fourfold rally a...
General Motors has boosted its 2026 profit outlook for the second time this year. This article breaks down which part...